On July 29, Bunge fell 5.66% in regular trading, trading at $111.91/share, with turnover of $16.154 million. Despite reporting Q2 results that broadly exceeded expectations, management's cautious forward commentary triggered selling pressure.

Bunge posted Q2 adjusted EPS of $2.00, beating the consensus estimate of $1.95-$1.97, representing a 52.67% increase from $1.31 a year earlier. Revenue reached $24.04 billion, up 88.3% year-over-year and approximately $1.2 billion above expectations. The company also raised its full-year adjusted EPS guidance to $9.25-$9.75, up from the prior range of $9.00-$9.50, compared with the analyst consensus of $9.42.

However, during the earnings call, management explicitly stated that the current commercial environment remains complex, with uncertainty in certain regions particularly pronounced heading into the fourth quarter. CEO Greg Heckman additionally warned that if supply disruptions persist, Argentine farmers may forgo investment in phosphate fertilizers. CFO John Neppl noted the company will likely deploy more capital into working capital in the second half amid strong market conditions.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)